Ditchcarbon
  • Contact
  1. Organizations
  2. Sinopharm Group Co. Ltd.
Public Profile
Pharmaceutical Preparation Manufacturing
CN
updated 23 days ago

Sinopharm Group Co. Ltd.

Company website

Sinopharm Group Co. Ltd., a leading player in the pharmaceutical and healthcare industry, is headquartered in Beijing, China. Founded in 1998, the company has established itself as a pivotal force in the distribution of pharmaceuticals, medical devices, and healthcare services across various regions, including Asia, Europe, and Africa. With a diverse portfolio that includes vaccines, blood products, and diagnostic reagents, Sinopharm is renowned for its commitment to innovation and quality. The company has achieved significant milestones, such as being a key supplier of COVID-19 vaccines, which has bolstered its market position globally. Sinopharm's extensive distribution network and strong partnerships further enhance its reputation as a trusted provider in the healthcare sector, making it a cornerstone of China's pharmaceutical landscape.

DitchCarbon Score

How does Sinopharm Group Co. Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

43

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

31

Industry Benchmark

Sinopharm Group Co. Ltd.'s score of 43 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.

64%

Let us know if this data was useful to you

Sinopharm Group Co. Ltd.'s reported carbon emissions

In 2024, Sinopharm Group Co. Ltd. reported total carbon emissions of approximately 544,381,900 kg CO2e. This figure includes 48,785,710 kg CO2e from Scope 1 emissions, 177,259,360 kg CO2e from Scope 2 emissions, and 318,336,830 kg CO2e from Scope 3 emissions. The company's emissions for 2023 were about 263,415,270 kg CO2e, with Scope 1 emissions at 54,715,050 kg CO2e and Scope 2 emissions at 208,700,220 kg CO2e. Sinopharm has set ambitious climate commitments, aiming for net zero emissions by 2030 for both Scope 1 and Scope 2 emissions. This commitment was established in 2023 and reflects the company's proactive approach to addressing climate change. The reduction targets are part of a broader strategy to enhance sustainability within its operations. The emissions data is cascaded from Sinopharm Group Co. Ltd. as the source organization, indicating a structured approach to environmental reporting and accountability. The company continues to focus on reducing its carbon footprint while maintaining its position in the global market.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2018201920202021202220232024
Scope 1
30,741,540
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
88,611,470
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 3
-
-
-
-
-
-
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Sinopharm Group Co. Ltd.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Sinopharm Group Co. Ltd. is in CN, which we do not have grid emissions data for.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Sinopharm Group Co. Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Guangdong Dashenlin Chain Drugstore Co., Ltd.

CN
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Merck And Co

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Shanghai Pharmaceuticals

CN
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Sanofi

FR
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

Chongqing Tongjunge Pharmacy Chain Co.,Ltd.

CN
•
Pharmaceutical Preparation Manufacturing
Updated 21 days ago

Glaxosmithkline

GB
•
Pharmaceutical Preparation Manufacturing
Updated 5 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251005.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy